Identity of single-nucleotide polymorphisms used in a clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy: Comment on the article by Wessels et alCitation formats

Standard

Identity of single-nucleotide polymorphisms used in a clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy: Comment on the article by Wessels et al. / Warren, R. B.; Gibbons, L. J.

In: Arthritis Care & Research, Vol. 58, No. 4, 04.2008, p. 1204-1205.

Research output: Contribution to journal › Article › peer-review

Harvard

Warren, RB & Gibbons, LJ 2008, 'Identity of single-nucleotide polymorphisms used in a clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy: Comment on the article by Wessels et al', Arthritis Care & Research, vol. 58, no. 4, pp. 1204-1205. https://doi.org/10.1002/art.23414

APA

Warren, R. B., & Gibbons, L. J. (2008). Identity of single-nucleotide polymorphisms used in a clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy: Comment on the article by Wessels et al. Arthritis Care & Research, 58(4), 1204-1205. https://doi.org/10.1002/art.23414

Vancouver

Warren RB, Gibbons LJ. Identity of single-nucleotide polymorphisms used in a clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy: Comment on the article by Wessels et al. Arthritis Care & Research. 2008 Apr;58(4):1204-1205. https://doi.org/10.1002/art.23414

Author

Warren, R. B. ; Gibbons, L. J. / Identity of single-nucleotide polymorphisms used in a clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy: Comment on the article by Wessels et al. In: Arthritis Care & Research. 2008 ; Vol. 58, No. 4. pp. 1204-1205.

Bibtex

@article{2c320a7ec81041e787ceff2b61359ff1,
title = "Identity of single-nucleotide polymorphisms used in a clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy: Comment on the article by Wessels et al",
keywords = "therapeutic use: Antirheumatic Agents, drug therapy: Arthritis, Rheumatoid, Databases, Nucleic Acid, genetics: Glycine Hydroxymethyltransferase, Humans, therapeutic use: Methotrexate, genetics: Methylenetetrahydrofolate Dehydrogenase (NADP), Pharmacogenetics, genetics: Polymorphism, Single Nucleotide",
author = "Warren, {R. B.} and Gibbons, {L. J.}",
year = "2008",
month = apr,
doi = "10.1002/art.23414",
language = "English",
volume = "58",
pages = "1204--1205",
journal = "Arthritis Care & Research",
issn = "2151-464X",
publisher = "John Wiley & Sons Ltd",
number = "4",

}

RIS

TY - JOUR

T1 - Identity of single-nucleotide polymorphisms used in a clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy: Comment on the article by Wessels et al

AU - Warren, R. B.

AU - Gibbons, L. J.

PY - 2008/4

Y1 - 2008/4

KW - therapeutic use: Antirheumatic Agents

KW - drug therapy: Arthritis, Rheumatoid

KW - Databases, Nucleic Acid

KW - genetics: Glycine Hydroxymethyltransferase

KW - Humans

KW - therapeutic use: Methotrexate

KW - genetics: Methylenetetrahydrofolate Dehydrogenase (NADP)

KW - Pharmacogenetics

KW - genetics: Polymorphism, Single Nucleotide

U2 - 10.1002/art.23414

DO - 10.1002/art.23414

M3 - Article

VL - 58

SP - 1204

EP - 1205

JO - Arthritis Care & Research

JF - Arthritis Care & Research

SN - 2151-464X

IS - 4

ER -